PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Anthem BCBSCommercial · Prior Auth · Pharmacy · GA · Pharmacy, Hematology, Oncology +1 moreHigh impact

[Georgia] Specialty pharmacy updates — July 2026

Act
by Sep 15, 2026
Effective date
Oct 1, 2026
Identified
Jun 25, 2026

Summary

Effective October 1, 2026, Anthem Blue Cross and Blue Shield (Georgia) is implementing new prior authorization requirements for four specialty pharmacy drugs (Fesilty, Loargys, Vykoura, and Yuviwel), adding quantity limits to two drugs (Loargys and Yuviwel), and updating clinical criteria for eight drug classes that may result in previously covered services being denied as not medically necessary. Providers must begin requesting prior authorization for affected specialty medications on or after the effective date, and including NDC codes on claims will expedite processing.

Get alerts when payers change rules like this one

We check Anthem BCBS and other payers every day and email you when a change matches your specialty and state.

Get Anthem BCBS alertsPolicy Monitoring is free. No card required.

What to do

by Sep 15, 2026 · 8 steps
01Billing team and clinical staff must identify all patients currently receiving Fesilty (fibrinogen, human-chmt), Loargys (pegzilarginase-nbln), Vykoura (leucovorin calcium), or Yuviwel (navepegritide) to prepare for prior authorization requirements.
02Update billing software to require prior authorization submission for HCPCS codes C9399, J3590, and J3490 billed with clinical criteria CC-0149, CC-0301, CC-0104, and CC-0300 effective October 1, 2026.
03Implement quantity limit controls in billing system for Loargys (J3590) and Yuviwel (J3490).
04Train all providers and coding staff on the eight updated clinical criteria documents (CC-0003, CC-0058, CC-0065, CC-0104, CC-0124, CC-0128, CC-0142, CC-0236) to ensure medical necessity documentation is complete before claim submission.
05Note that oncology use of Vykoura (leucovorin calcium) is managed by Carelon Medical Benefits Management, not Anthem's specialty drug review team.
06Ensure NDC codes are included on all specialty pharmacy claims to expedite processing.
07Beginning October 1, 2026: Do not submit claims for affected specialty pharmacy drugs without prior authorization—claims will be denied.
08Reference Anthem's provider portal at https://anthem.com/provider for complete clinical criteria documents.

Codes mentioned

C9399J3590J3490

Original notice

[Georgia] Specialty pharmacy updates — July 2026
providernews.anthem.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account